Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Umekita, Yoshihisa ^a   Ohi, Yasuyo ^b   Souda, Masakazu ^a   Rai, Yoshiaki ^b   Sagara, Yoshiaki ^b   Sagara, Yasuaki ^b   Tamada, Shugo ^b   Tanimoto, Akihide ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SAGARA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; KERATIN-14; KERATIN-5; KERATIN-6; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955084126     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-36     Document Type: Article

References (12)

1. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveau M, Sheng S, Rafidi K, Seftor E, Sagar R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994, 263:526-529. 10.1126/science.8290962, 8290962.
2. Rakha EA, Ellis IO. Triple-negative/basal-like breast cancer: review. Pathology 2009, 41:40-47. 10.1080/00313020802563510, 19089739.
3. Umekita Y, Ohi Y, Sagara Y, Yoshida H. Expression of maspin predicts poor prognosis in breast cancer patients. Int J Cancer 2002, 100:452-455. 10.1002/ijc.10500, 12115529.
4. Umekita Y, Yoshida H. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Histopathology 2003, 42:541-545. 10.1046/j.1365-2559.2003.01620.x, 12786889.
5. Rakha EA, Putti TC, El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 2006, 208:495-506. 10.1002/path.1916, 16429394.
6. Umekita Y, Souda M, Ohi Y, Sagara Y, Rai Y, Takahama T, Yoshida H. Expression of wild-type estrogen receptor β protein in human breast cancer: Specific correlation with HER2/neu overexpression. Pathol Int 2006, 56:423-427. 10.1111/j.1440-1827.2006.01983.x, 16872435.
7. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown A, Gilks CB, van de Rijn M, Perou CM. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374. 10.1158/1078-0432.CCR-04-0220, 15328174.
8. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJC. Biological function of maspin. J Cell Phisiol 2006, 209:617-624.
9. Jones C, Nonni AV, Fuitord L, Merrett S, Chaggar R, Eusebi V, Lakhani SR. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 2001, 85:422-427. 10.1054/bjoc.2001.1869, 2364069, 11487275.
10. Liu T, Pemberton PA, Robertson AD. Three-state unfolding and self association of maspin, a tumor-suppressing serpin. J Biol Chem 1999, 274:29628-29632. 10.1074/jbc.274.42.29628, 10514431.
11. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: A critical review. J Clin Oncol 2008, 26:2568-2581. 10.1200/JCO.2007.13.1748, 18487574.
12. Foulkes WD, Smith IE, Reis-Filho JS. Triple-nagtive breast cancer. New Engl J Med 2010, 363:1938-1948. 10.1056/NEJMra1001389, 21067385.